Protocol summary

Study aim
A comparative study on the sedative and analgesic effects of remifentanil and combined propofol and fentanyl in patients with shoulder dislocation
Design
This study is performed on 60 patients referring to the emergency department of Rasht Poursina hospital, with acute anterior shoulder dislocation requiring closed reduction. The patients are placed in two groups by random block method. Random sequences are generated with a 1:1 ratio using the random generator program. Generated sequences or labels A and B are put in sealed envelopes at the emergency nursing station. This study is done in phase three.
Settings and conduct
This study is performed on the patients of emergency department of Poursina Hospital in Rasht, with shoulder dislocation. After receiving the desired sedative drug (remifentanil or combined fentanyl and propofol), the patients will be examined in terms of success in reducing shoulder joint dislocation, complications (agitation, nausea, vomiting, apnea), pain (score 1 to 10 based on VAS criteria), trouble-free shoulder reduction, the length of stay in the emergency ward for recovery, the duration of the analgesic and sedative effects, and the need for re-injection. The present study is double-blind. An emergency medical specialist working in the hospital gives drugs according to the generated sequences in the same covered encoded syringes to the related residents without having any information on them, and if re-injection is necessary, s(he) will give them the medicine. Also, the patient and the person evaluating the outcome are not aware of the type of injectable drugs.
Participants/Inclusion and exclusion criteria
Inclusion Criteria: The patients referring to the emergency ward of Rasht Poursina hospital, with acute anterior shoulder dislocation requiring closed reduction. Exclusion Criteria: The patients who have been diagnosed with fracture-dislocation of the shoulder joint, except those suffering from Hill-Sachs lesions The patients with decreased Glasgow coma scale (GCS) The patients with immature skeletal system (open epiphysis) or the patients who have undergone surgery beforehand and have had a fracture in the same shoulder The patients who are allergic to soy and eggs The patients with reduced blood pressure The patients with heart failure The patients over the age of 60 and under the age of 15 years
Intervention groups
Intervention group: Remifentanil group. A group of patients referring to the emergency ward of Pursina hospital in Rasht, with an acute anterior shoulder dislocation needing closed reduction, taking remifentanil drug for relieving pain. Control group: Combined propofol and fentanyl. A group of patients referring to the Emergency Department of Pursina hospital in Rasht, with acute anterior shoulder dislocation requiring closed reduction, taking combination of propofol and fentanyl for relieving pain.
Main outcome variables
Side effects; starting time for the reduction after the medication injection; severity of pain; trouble-freeness in joint reduction; stay length in the emergency ward; the need for re-injection of the medication; the duration of analgesic effect after injection

General information

Reason for update
Acronym
PSA, VAS, ED
IRCT registration information
IRCT registration number: IRCT20110818007369N6
Registration date: 2018-02-21, 1396/12/02
Registration timing: retrospective

Last update: 2018-02-21, 1396/12/02
Update count: 0
Registration date
2018-02-21, 1396/12/02
Registrant information
Name
Firouz Behboudi
Name of organization / entity
Gilan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 13 3336 8773
Email address
info@gtrc.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2017-10-23, 1396/08/01
Expected recruitment end date
2017-12-21, 1396/09/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of Remifentanil with Combined Propofol and Fentanyl Medications for Sedative and Analgesic Effects on Patients with Anterior Shoulder Dislocation Treated by Closed Reduction, A Double-Blind Randomized Clinical Trial
Public title
Comparison of Remifentanil with Combined Propofol and Fentanyl Medications for Sedative and Analgesic Effects in the Treatment of Shoulder Dislocation
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
The patients referring to the emergency department of Poursina hospital with acute anterior shoulder dislocation requiring closed reduction
Exclusion criteria:
The patients who have been diagnosed with fracture-dislocation of the shoulder joint, except those suffering from Hill-Sachs lesions The patients with decreased GCS and unstable hemodynamic status The patients with immature skeletal system (open epiphysis) or the patients who have undergone surgery previously and have had a fracture in the same shoulder The patients who are allergic to soy and eggs The patients with reduced blood pressure (Systolic Blood Pressure<90 mm Hg) The patients with heart failure The patients over the age of 60 and under the age of 15 years
Age
From 15 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
According to the sample size calculated in this study, which equals to 30 patients in each group, they are randomly placed in two groups by random block method. Random sequences are generated with a 1:1 ratio using the random generator program. Generated sequences or labels A and B are put in sealed envelopes at the Emergency Nursing Station.
Blinding (investigator's opinion)
Double blinded
Blinding description
The present study is double-blind. An emergency medical specialist working in the hospital gives drugs according to the generated sequences in the same covered encoded syringes to the related residents without having any information on them, and if re-injection is necessary, s(he) will give them the medicine. Also, the patient and the person evaluating the outcome are not aware of the type of injectable drugs.
Placebo
Not used
Assignment
Parallel
Other design features
-

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Guilan University of Medical Sciences
Street address
Deputy of Research and Technology, opposite to 17 Shahrivar Hospital, Shahid Siadati St., Namjoo Ave.
City
Rasht
Province
Guilan
Postal code
4144666949
Approval date
2017-10-21, 1396/07/29
Ethics committee reference number
IR.GUMS.REC.1396.271

Health conditions studied

1

Description of health condition studied
anterior shoulder dislocation
ICD-10 code
S43.0
ICD-10 code description
Unspecified subluxation and dislocation of shoulder joint

Primary outcomes

1

Description
Amount of side effects following drug injection such as agitation, nausea, vomiting, and apnea
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
Based on the resident report

2

Description
Starting time of reduction after the drug injection
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
Since drug injection until patient sedation in seconds

3

Description
Severity of pain
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
The severity of pain before, during, and after joint reduction is measured according to the visual analogue scale based on the patient's statement.

4

Description
Amount of trouble-freeness in the shoulder joint reduction
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
Based on the resident report

5

Description
Stay length in the emergency ward
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
Since the beginning of injection until the end of the recovery (full consciousness) in the patient in minutes

6

Description
The need for re-injection of the drug
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
The inadequacy of the sedative and analgesic effects leading to re-inject repeated dose of the drug

7

Description
Duration analgesic effect after the drug injection
Timepoint
1, 5, 10 and 20 minutes after shoulder reduction
Method of measurement
Duration of the sedative and analgesic effects after the injection in minutes

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Remifentanil (1 μg/kg) will be injected intravenously. Remifentanil (0.5 μg/kg) can be repeated three times at the most, and if needed, the drug will be injected after measuring visual analogue scale.
Category
Treatment - Drugs

2

Description
Control group:A combination of propofol (1 mg/kg) and fentanyl (1 μg/kg) will be injected intravenously. For reinjection, the dose of propofol is 0.5 mg/kg, and if needed, the drugs will be injected after measuring visual analogue scale.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Poursina Hospital
Full name of responsible person
Marjan Aghajani Nargesi
Street address
Poursina Hospital, Poursina Crossroads, Namjoo Ave.
City
Rasht
Province
Guilan
Postal code
4193713194
Phone
+98 13 3336 8773
Fax
+98 13 3333 9842
Email
info@gtrc.ir
Web page address
http://www.gums.ac.ir/poursina

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Dr. Shadman Nemati
Street address
Opposite 17 Shahrivar Hospital, Shahid Siadati St., Namjoo Ave.
City
Rasht
Province
Guilan
Postal code
4144666949
Phone
+98 13 3333 6394
Fax
+98 13 3332 4168
Email
research@gums.ac.ir
Web page address
http://www.gums.ac.ir/research
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Rasht University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Marjan Aghajani Nargesi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Emergency Medicine
Street address
Unit 2, 1st Floor, No. 11, St. 186, Guilan Blvd., Golsar
City
Rasht
Province
Guilan
Postal code
4166813315
Phone
+98 13 3377 4858
Email
info@gtrc.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Vahid Monsef Kasmaei
Position
Associate Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Poursina Hospital, Poursina Crossroads, Namjoo Ave.
City
Rasht
Province
Guilan
Postal code
4193713194
Phone
+98 13 3332 2444
Fax
+98 13 3333 9842
Email
vmonsef@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Rasht University of Medical Sciences
Full name of responsible person
Marjan Aghajani Nargesi
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Emergency Medicine
Street address
Unit 2, 1st Floor, No. 11, St. 186, Guilan Blvd., Golsar
City
Rasht
Province
Guilan
Postal code
4166813315
Phone
+98 13 3377 4858
Email
info@gtrc.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...